Drug intelligence / Profile preview

proline-type fullerene derivative P3

Development stage
Preclinical
Modality
Nanoparticles → Drug Delivery Systems, Small Molecules
01

Overview

Proline-type fullerene derivative P3 is a water-soluble chemical compound derived from the functionalization of a C60 fullerene core with three carboxy groups and proline moieties. It has been studied for its biological activity in inhibiting adipogenesis (the formation of fat cells) in vitro. Specifically, it suppresses lipid accumulation and the expression of adipocyte-specific genes such as aP2 in preadipocyte cell models by preventing activation of peroxisome proliferator-activated receptor gamma (PPARγ), a key regulator of adipocyte differentiation. Unlike other related derivatives with only two carboxy groups, the tri-carboxylated structure of P3 is critical for its anti-adipogenic effect. The compound has shown potential anti-obesity activity at the cellular level but does not affect upstream regulators like C/EBPδ or C/EBPβ[1].

Other names
P3 fullereneP-3 fullereneP 3 fullereneproline-type C60 derivative P3
02

Targets

PPARG (Peroxisome proliferator-activated receptor gamma)

Beyond the preview

Go deeper on proline-type fullerene derivative P3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on proline-type fullerene derivative P3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call